Booth Andrew — SEC insider filings
SEC reporting owner CIK 1834411. 17 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2021-06-09 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 6 filings — 255,400 shares, $2,211,639 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,200,000 shares, $30,600,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 1,200,000 shares @ $25.50 ($30,600,000) in AbCellera Biologics Inc., filed 2021-06-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | Chief Financial Officer | 17 | 7 legs · 255,400 sh · $2,211,639 | 1 leg · 1,200,000 sh · $30,600,000 | 19 |
Insider filings — Booth Andrew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | AbCellera Biologics Inc. (ABCL) | Option exercise (M): 50,000 @ $0.32 · Gift (G): 50,000 @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 8,600 @ $11.33 | EDGAR |
| 2026-08-14 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 37,200 @ $10.32 | EDGAR |
| 2026-06-03 | 4 | AbCellera Biologics Inc. (ABCL) | Option exercise (M): 250,000 @ $0.19 · Option exercise (M): 250,000 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 42,600 @ $3.42 | EDGAR |
| 2026-01-05 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 808,898 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 1,352,054 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 770,416 (derivative) @ $0 | EDGAR |
| 2023-05-26 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 14,500 @ $6.85 | EDGAR |
| 2022-12-22 | 4 | AbCellera Biologics Inc. (ABCL) | Option exercise (M): 50,000 @ $0.19 · Gift (G): 50,000 @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2022-12-05 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 485,661 (derivative) @ $0 | EDGAR |
| 2022-05-16 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 85,000 @ $5.79 | EDGAR |
| 2021-12-10 | 4 | AbCellera Biologics Inc. (ABCL) | Option exercise (M): 500,000 @ $0.32 · Option exercise (M): 500,000 (derivative) @ $0 | EDGAR |
| 2021-12-09 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 406,020 (derivative) @ $0 | EDGAR |
| 2021-11-15 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 53,500 @ $14.74 · Purchase (P): 14,000 @ $14.61 | EDGAR |
| 2021-06-10 | 4 | AbCellera Biologics Inc. (ABCL) | Sale (S): 1,200,000 @ $25.50 | EDGAR |
| 2021-06-09 | 4 | AbCellera Biologics Inc. (ABCL) | Option exercise (M): 600,000 @ $0.19 · Option exercise (M): 600,000 @ $0.32 · Option exercise (M): 600,000 (derivative) @ $0 · Option exercise (M): 600,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834411 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs